Q
QuantLogix.ai

Weekly Market Recap — AI Jitters, Hot CPI, Record Gold

Week ending Friday, October 17, 2026 · Published by QuantLogix Research

Risk Regime: OFF VIX 20.0 (+21% WoW) 10Y Yield 5.10% Brent $110

Index Scoreboard

Weekly % change — broad market
S&P 500
6,620
−1.95%
Nasdaq Composite
26,360
−4.50%
Dow Jones
52,160
+1.50%
Russell 2000
2,345
−2.80%
10Y Treasury
5.10%
yields firm
VIX
19.99
+21%
Brent Crude
$109.84
+6.1%
Gold Spot
$4,075
+1.4% (record)

Levels are approximate end-of-week prints; weekly % tracks Friday-to-Friday close. Nasdaq's draw was the worst since the week ended June 27 and ended a month-long winning streak.

Sector Heatmap

S&P 500 sectors — weekly % change
Health Care
+2.1%
Energy
+2.0%
Financials
+1.3%
Utilities
+0.6%
Staples
+0.1%
Industrials
−0.4%
Materials
−0.7%
Real Estate
−1.1%
Comm Services
−3.2%
Technology
−5.0%

Classic risk-off dispersion: health care at record highs, financials buoyed by trading desks, energy riding a Hormuz-driven oil bid. Technology took the sharpest hit as AI–cap-ex financing math came under the microscope.

Macro & Policy

Inflation reaccelerates, Fed path repriced

CPI 3.7% YoY shifts the dot plot

September headline CPI printed +3.7% YoY, hotter than consensus and the warmest reading of the year, with Bank of America noting 55% of the core basket running above a 2.5% annualized three-month pace. Shelter and services inflation stayed sticky; goods disinflation cooled.

The reaction across rates was immediate: the 10-year yield firmed to ~5.10% (the 30-year near 5.42%), curve flattening resumed, and traders cut the probability of an October hike from ~33% intraweek to ~15% by Friday — still leaving roughly one quarter-point hike priced into year-end. The dollar firmed; growth-sensitive assets wobbled.

QuantLogix read

The “last mile” of disinflation remains unfinished. With oil pushing back toward $110 on Hormuz escalation and tariffs re-entering the discourse, the probability of a renewed inflation impulse into Q1 2027 is non-trivial. We model Fed pause as the base case, with hike risk back on the table.

Rates & Policy Dashboard
Headline CPI (YoY)
3.7%
Core CPI (YoY)
3.2%
Fed funds target
4.00–4.25%
Dec hike probability
~55%
2Y Treasury
4.42%
10Y Treasury
5.10%
30Y Treasury
5.42%
USD Index (DXY)
104.1
Brent crude
$109.84
WTI crude
$99.72

Market stress gauge

CalmElevated

Technology & AI

The AI financing question lands

From “spend more” to “show the receipts”

What began as isolated chatter about hyperscaler capex payback hardened this week into a measurable risk-off move in AI infrastructure. CoreWeave (CRWV) was the fulcrum: shares shed ~12% as its 2029 secured notes yielded above 15%, implying genuine credit stress for a benchmark Nvidia-backed data-center operator. The SOXX semiconductor ETF printed a ninth-straight down session, its worst eight-session stretch since April 2025.

Yet the fabrication layer told a different story. TSMC posted record Q3 revenue of T$1.49 trillion (~$46.7B, +50% YoY), beating both consensus and its own prior guidance range. September revenue alone was +54.6% YoY. The read-through: demand at the silicon workbench remains structurally healthy; the stress is at the monetization and financing layer above it — which is exactly where valuations stretch thinnest.

Software and cloud (SaaS, hyperscalers) outperformed chips modestly intraweek before giving it back Friday. Meta −3.7%, Netflix −2.9%, Microsoft −1.8%, Palantir ~−7%. Nvidia's print now carries unusual weight — a decisive beat with upward Blackwell/Rubin visibility could reset positioning; a soft tone would validate the funding anxiety.

AI/Tech — weekly movers
NameWoW
CRWV
CoreWeave
−11.9%
PLTR
Palantir
−7.0%
META
Meta Platforms
−3.7%
NFLX
Netflix
−2.9%
TSLA
Tesla
−2.1%
MSFT
Microsoft
−1.8%
TSM
TSMC (ADR)
+1.8%
AI capex scrutiny Credit spreads widening NVDA print next

Defense & Aerospace

Pentagon spending + geopolitics = tailwind

Defense primes caught a bid under rotation

With Iran escalating in the Strait of Hormuz and the Trump administration's China rhetoric intensifying, the defense complex absorbed capital from rotating tech money. Pentagon modernization budgets remain upwardly skewed, and four of the five large primes (LMT, NOC, RTX, GD) are consistently raising dividends on long-tail backlogs.

Lockheed Martin (LMT) extended its uptrend as munitions replenishment, F-35 sustainment and hypersonic funding feed through to orders. Shipbuilders and electronic-warfare names continued to find premium multiples. Shielded by multi-year contracts, this cohort behaves closer to utilities than to cyclicals — a feature in a late-cycle, risk-off tape.

QuantLogix model view

Our defense factor basket flipped to “Overweight” on Tuesday as our geopolitical-stress composite crossed the 70th percentile. Fundamental: book-to-bill > 1.1 across the top four primes; relative strength vs. S&P: +7.8% over 90 days.

Defense — weekly tape
NameWoW
LMT
Lockheed Martin
+3.1%
RTX
RTX Corp.
+2.6%
NOC
Northrop Grumman
+2.2%
GD
General Dynamics
+1.9%
LHX
L3Harris
+1.4%
HII
Huntington Ingalls
+1.1%
LDOS
Leidos
+0.9%
Hormuz premium Dividend risers

Biotech & Healthcare

Clinical de-risking is paying up — selectively

Healthcare at record highs even as beta names chop

The S&P 500 Health Care sector (XLV) hit a record high intraweek, led by large-cap pharma, device makers and managed care rebounding off defensive-rotation flows. Beneath the index, biotech dispersion remained extreme: the XBI biotech ETF is +23% YTD while mega-cap single names like Moderna (MRNA) are up ~600% YTD, with the melanoma vaccine partnership with Merck re-rating the pipeline since August's Phase 3 readout. MRNA did finish the week lower (~−9%) on profit-taking into the medical-meeting data later this month.

Deal activity continues to concentrate at the obesity/metabolic frontier and “molecular glue” chemistry. Roche has announced five China-biotech deals worth $5B+ since late August; GSK and AstraZeneca have each run similar playbooks for 20+ months.

Our takeaway: the market is paying real option value for binary clinical events, but only where the data is unambiguous. Mid-cap biotech still trades like a correlation trade to credit spreads — which widened this week.

Biotech & health — weekly tape
NameWoW
LLY
Eli Lilly
+4.2%
UNH
UnitedHealth
+3.1%
JNJ
Johnson & Johnson
+2.3%
VRTX
Vertex Pharma
+1.9%
REGN
Regeneron
+1.5%
XBI
SPDR Biotech ETF
−0.8%
MRNA
Moderna
−9.0%
GLP-1 franchise Clinical de-risking XLV all-time high

Q3 Earnings Spotlight — Big Banks

Trading desks offset net-interest-income pressure
BankRevenueNet IncomeDiluted EPSNotable
JPM
JPMorgan Chase
$50.2B $15.3B $5.57 $5.75 ex-securities loss; dividend/buyback intact
GS
Goldman Sachs
$18.7B $5.3B $17.01 Trading, investment banking both strong
MS
Morgan Stanley
$20.3B $4.9B $3.03 Wealth management ~$6T AUM milestone
C
Citigroup
$23.8B $5.2B $2.85 EPS +53% YoY; markets & services led
WFC
Wells Fargo
$21.9B $6.0B $1.87 NIM stable; expense discipline
BAC
Bank of America
$30.0B $6.9B $0.91 $1.08 adj. after $1.2B regulatory charge

Across the six, record trading revenue (volatility harvest), reserve releases on consumer credit, and resilient fee lines offset slower loan growth and higher deposit costs. The group ended the week green, with Financials (XLF) one of three positive S&P sectors.

Commodities, FX & Crypto

Precious metals & energy

Gold shatters $4,000, silver pins $51

Gold spot touched a record $4,079.70/oz and closed near $4,075 (+1.4% on Friday alone), carried by renewed U.S.-China tariff rhetoric, central-bank buying and ETF inflows. YTD gold is +53%. Silver kissed a record $51.70/oz before easing; both metals print RSIs in the 80s — stretched, but momentum intact.

In energy, Brent spiked to $110 intraweek on Iran-Hormuz escalation, with WTI nearing $100. Oil's bid is both geopolitical and inflationary — a key crosswind for the Fed path and a tailwind for XLE.

Gold spot
$4,075.24
Silver spot
$51.03
Platinum
$1,641
Palladium
$1,442
Brent crude
$109.84
WTI crude
$99.72
Nat gas
$3.42
Copper
$4.78
Currencies & crypto

Dollar firm, Bitcoin consolidates

The dollar firmed modestly on hot CPI and yield support, though gains were muted by safe-haven competition from precious metals. The yen weakened past 155/USD as the BoJ held, pressuring Asian risk assets. The euro was flat to a touch softer vs. USD.

Crypto was mixed in a classic de-risk week: Bitcoin held around $81,600 (−0.5% Friday, roughly flat on the week), finding support at the 200-day. Ethereum underperformed, with the ETH/BTC ratio drifting lower. XRP and select large caps continued to drive weekly ETF inflow headlines.

DXY (dollar index)
104.1
EUR/USD
1.062
USD/JPY
155.4
GBP/USD
1.238
Bitcoin
$81,608
Ethereum
$3,185
Solana
$168
Total crypto cap
$3.2T

What to Watch Next Week

Earnings on deck

Mega-cap tech + healthcare

Headline reporters next week include Netflix, Tesla, IBM, Verizon, Coca-Cola, Johnson & Johnson, Procter & Gamble, General Motors, Boeing, Lockheed Martin, and additional regional banks. Credit guidance tone across industrials will matter more than top-line beats; defense primes' order books are the proxy for 2027 Pentagon flow.

The AI narrative pivot date is Nvidia's print in three weeks — any supplier color (optics, HBM, substrates, power) in the next two weeks can precondition positioning.

Macro calendar

Data & speakers

Monday: Fed speakers (Williams, Jefferson) · Tuesday: Existing home sales · Wednesday: Fed Beige Book · Thursday: Weekly jobless claims, S&P flash PMIs (manufacturing, services) · Friday: UMich consumer sentiment (final), durable goods proxy.

FOMC decision is October 28–29: current pricing favors a hold, but any Fed-speak lean this coming week could meaningfully reprice the December path. The 10-year's defense of 5.10% is the key technical anchor.